Printer Friendly

MAPLE ISLAND AND FDA ANNOUNCE INFANT FORMULA RECALL

 MOUNT VERNON, Ohio, June 23 /PRNewswire/ -- The manufacturer of Soyalac(R) Powder, in cooperation with the U.S. Food and Drug Administration, today announced the extension of a recall involving Soyalac Powder. The powdered infant formula subject to recall was converted into powder and packaged by Maple Island, Inc., a contract manufacturer, at Maple Island's food plant in Wanamingo, Minn.
 FDA has learned that Maple Island Inc.'s Wanamingo facility, part of which Maple Island shut down on June 8, 1993, harbored salmonella, a bacteria that can cause gastrointestinal illness if consumed. The recall is being undertaken because of the potential that the powdered infant formula was contaminated with salmonella during the time that it was being processed and/or packaged by Maple Island, Inc.
 Soyalac liquid infant formula (both ready-to-use and concentrate) and I-Soyalac infant formula (powder, ready-to-use and concentrate) are not involved in this recall. Maple Island was never involved in the manufacturing of these infant formulas, and those products can continue to be used with the assurance that they are safe and wholesome.
 This recall applies to 14 oz. (400 g) cans of Soyalac Powder. The cans will have the code number W5330 on the bottom of the can. If you have any product subject to this recall, do not use it, and return it to the place of purchase for replacement or a refund. You can substitute Soyalac concentrate or ready-to-use, or I-Soyalac powder, ready-to-use or concentrate infant formulas, with the assurance that they are safe and wholesome for your child.
 -0- 6/23/93
 /CONTACT: Maple Island Consumer Affairs Department, 800-932-5525/


CO: Maple Island, Inc. ST: Ohio IN: FOD SU:

CK-SH -- NY015 -- 4948 06/23/93 10:47 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 23, 1993
Words:284
Previous Article:BROOKLYN UNION SHAREHOLDERS APPROVE STOCK SPLIT
Next Article:RTC'S JULY CALIFORNIA AUCTION FEATURES EXCITING COMMERCIAL PROPERTIES: ALL PROPERTIES SOLD INDIVIDUALLY
Topics:


Related Articles
FOOD PROCESSORS SAY FDA STUDY SHOWS SAFETY OF CHILDREN'S FOODS
ABBOTT LABORATORIES ISSUES CLARIFICATION OF INFANT FORMULA PRESS RELEASE
FDA ANNOUNCES RECALL OF POWDERED PRODUCTS
WYETH-AYERST SAYS ITS FORMULA PRODUCTS, SMA(R) AND NURSOY(R), NOT CITED BY FDA IN RECALL
Martek's Oils Added to Nestle U.S. Infant Formula.
Martek Signs Two New Infant Formula Licensees.
Nestle submits health claim petition to FDA.
FSA warns baby milk ink chemical alert could spread to UK.
Ink could be found in baby's milk.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters